Biomarkers

Precision for Medicine acquires ACT Oncology

Precision for Medicine acquires ACT Oncology

By

The scientific services company expands its portfolio to include expertise in oncology clinical studies.

Roche diagnostic unit partnering with drugmaker on companion diagnostic

The test seeks to identify patients with metastatic pancreatic cancer and high levels of hyaluronan.

OPINION

Email Newsletters